top of page
Definitions, patient care strategies, and treatment options for intermediate risk bladder cancer

This lesson is only available on the BackTable mobile app.

BackTable Urology

Lesson 6  •  17 Jul 2025

Definitions, patient care strategies, and treatment options for intermediate risk bladder cancer

Course overview

This course covers the management of intermediate risk NMIBC, including diagnostic strategies, treatment advancements, BCG refractory cases, adjuvant therapies, with insights from leading experts in oncology and urology.

1.5 hours, 17 lessons

Lessons

Patient-Centered Treatment Strategies with Dr. Kelly Bree



Lesson 1

Risk stratification for patients with intermediate risk bladder cancer



Lesson 2

Quality of life, counseling, and treatment strategies for bladder cancer patients



Lesson 3

Patient preparation and in-office procedures for low-grade tumors



Lesson 4

Criteria for in-office fulguration, recurrence timelines, and patient resources for bladder cancer



Lesson 5

Patient-centered treatment options and research for intermediate risk NMIBC





Intravesical Therapies for Intermediate Risk Bladder Cancer with Dr. Lindsey Herrel



Lesson 6

Definitions, patient care strategies, and treatment options for intermediate risk bladder cancer



Lesson 7

Patient management challenges and new FDA-approved agents for bladder cancer



Lesson 8

Delivery methods in bladder cancer treatments, focusing on quality of life



Lesson 9

Cost-effective therapeutic approaches to NMIBC



Lesson 10

Improving intermediate risk disease outcomes through guidelines, biomarkers, and patient counseling





BCG Shortage: Salvaging Bladder Cancer Care with Dr. Amy Luckenbaugh



Lesson 11

The Challenge of BCG Shortages in Bladder Cancer Treatment



Lesson 12

Strategies For Managing BCG Shortages In Bladder Cancer Therapy



Lesson 13

New Therapies For Intermediate Risk Patients Beyond Traditional BCG Treatments



Lesson 14

Analyzing Bladder Cancer Treatments, Efficacy Of Gemcitabine, Docetaxel, And TAR-200



Lesson 15

New Treatments Options For BCG Refractory Bladder Cancer



Lesson 16

BCG Alternatives, Patient Quality Of Life, And Future Guidelines



Lesson 17

Supply Chain Resilience And BCG Allocation Strategies Amid Shortages

Access the full course for free on the BackTable mobile app.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page